Best Lutetium-177 therapy doctors in Israel: TOP 6 doctors

Prof. Merimsky leads the Unit for Orthopedic Oncology at Sourasky Medical Center, specializing in advanced therapies like Lutetium-177.

• Over 41 years of experience of experience in oncology and sarcoma treatment
• ESMO Faculty member for soft tissue and bone sarcoma
• Fellowship-trained at Institut Gustave Roussy in Paris
• Published extensively on bone and soft tissue malignancies

Leading expert in Lutetium-177 therapy – Dr. Raphael integrates cutting-edge genomic profiling with targeted radionuclide treatments at Sourasky Medical Center.

• Senior lecturer and PI for multiple clinical trials in oncology
• Specializes in thoracic malignancies and advanced phase clinical trials
• Member of ESMO and IASLC, focusing on innovative treatments
• Leader of the Israeli National Genomic Medicine Initiative in oncology
• Outstanding teacher at Tel-Aviv University Faculty of Medicine

Director of oncology hospitalization at Sourasky Medical Center – Dr. Stepfansky specializes in advanced treatment protocols.

• 26 years of experience of experience in oncology, including research roles
• Primary and secondary researcher for phase 1-3 clinical studies
• Specializes in internal medicine and oncology
• Practiced at leading medical centers in Belarus and Israel

Dr. Inna Ospovat leads the nuclear therapy department at Ichilov Clinic, specializing in Lutetium-177 PRRT – a breakthrough for neuroendocrine tumors.

• Specializes in radiation therapy for gastrointestinal and lung cancers
• Trained in oncology and radiation therapy at Hadassah University Hospital
• Member of ASTRO and ISCORT
• Fellowship at PMH University Hospital in Toronto

Professor Rifaat Safadi leads the liver disease unit at Hadassah Medical Center, specializing in advanced treatments like Lutetium-177 therapy.

• Over 38 years of experience of experience in gastroenterology and hepatology
• Fellowship-trained at Sinai School of Medicine in New York
• Member of international liver study associations
• Author of numerous articles in hepatology
• Recipient of multiple scientific awards for liver research

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.